Similac · Abbott Laboratories
Similac NeoSure NEC Lawsuit — Pennsylvania Families
If your premature baby was fed Similac NeoSure in a Pennsylvania NICU and developed necrotizing enterocolitis, your family may qualify for compensation.
Two fast next steps for Similac NeoSure families:
About Similac NeoSure
Manufacturer: Abbott Laboratories
Similac NeoSure is Abbott's post-discharge cow's milk-based premature formula, sent home with NICU graduates and used in step-down units. NEC can develop both in the NICU and shortly after discharge, and NeoSure feeding is regularly cited in claims involving late-presenting NEC.
The Allegations Against Abbott Laboratories
Plaintiffs allege that Abbott Laboratories knew for decades that cow's milk–based premature formulas — including Similac NeoSure — significantly raise the risk of necrotizing enterocolitis (NEC) in preterm infants, yet failed to place adequate warnings on the label or in physician materials provided to NICU staff. As a result, parents could not give informed consent and NICU doctors could not weigh the documented risk against the alternative of donor human milk.
Recent verdicts include $495 million in Missouri (affirmed on appeal in May 2026), $70 million in Cook County (April 2026), and $32 million in Connecticut. Federal cases are consolidated in MDL 3026 before Judge Rebecca Pallmeyer, with the next bellwether trial set for July 6, 2026. Read the full litigation update and settlement projections.
Do You Qualify?
- ✓Baby born before 37 weeks (premature)
- ✓Fed Similac NeoSure in the NICU or after NICU discharge
- ✓Diagnosed with NEC by a surgeon or radiologist
- ✓NEC resulted in surgery, permanent injury, or death
- ✓Treated at a Pennsylvania hospital (or treated elsewhere but currently a PA family)
Take the four-question qualification checker or read the full Pennsylvania guide. Ready now? Jump to the free case review form.
Frequently Asked Questions
What is the NEC baby formula lawsuit?+
The NEC baby formula lawsuit is mass tort litigation against Abbott Laboratories (maker of Similac Special Care) and Mead Johnson Nutrition (maker of Enfamil Premature). Families allege these manufacturers failed to warn parents and NICU doctors that cow's milk–based premature formulas significantly increase the risk of necrotizing enterocolitis (NEC) in premature infants.
How much is an NEC lawsuit worth in Pennsylvania?+
Recent jury verdicts include $495 million in Missouri (affirmed on appeal in May 2026), $70 million in Cook County (April 2026), and $32 million in Connecticut. Individual settlements are currently projected between $50,000 and $500,000 or more, depending on the severity of injury, surgical history, and long-term complications.
Do I qualify for the NEC baby formula lawsuit?+
You may qualify if your baby was born premature (before 37 weeks), was fed Similac Special Care or Enfamil Premature formula in the NICU, was diagnosed with NEC by a surgeon or radiologist, and suffered surgery, permanent injury, or death as a result.
Is there a cost to file an NEC lawsuit?+
No. Case reviews are free and cases are handled on a contingency basis — you pay nothing unless your case results in a settlement or verdict. All costs are advanced by the law firm.
Free Case Review — Similac NeoSure Families
All information is confidential. There is no cost and no obligation.